on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Celebrates National Service Dog Month Highlighting Its Cancer Care Drugs
Jaguar Health, Inc. (NASDAQ:JAGX) celebrates National Service Dog Month by acknowledging the contributions of service dogs. Lisa Conte, Jaguar's CEO, highlights that service dogs enhance the quality of life for many, aligning with Jaguar's mission to support those suffering from complex diseases.
Canalevia®-CA1, Jaguar's FDA conditionally approved drug, treats chemotherapy-induced diarrhea (CID) in dogs. Available by prescription, this plant-based product emphasizes Jaguar's commitment to sustainable health solutions for animals.
The "Make Cancer Less Shitty" campaign amplifies Jaguar's dedication to supportive cancer care. Featuring stories from patient ambassadors, the campaign underscores the challenges and triumphs of living with cancer, sharing experiences via social media.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news